Cetera Advisor Networks’s Anavex Life Sciences AVXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-59,664
| Closed | -$555K | – | 2808 |
|
|
2023
Q4 | $555K | Sell |
59,664
-9,212
| -13% | -$85.8K | ﹤0.01% | 1793 |
|
|
2023
Q3 | $451K | Sell |
68,876
-14,802
| -18% | -$97K | ﹤0.01% | 1837 |
|
|
2023
Q2 | $680K | Buy |
83,678
+4,833
| +6% | +$39.3K | ﹤0.01% | 1518 |
|
|
2023
Q1 | $676K | Buy |
78,845
+9,287
| +13% | +$79.6K | 0.01% | 1483 |
|
|
2022
Q4 | $644K | Buy |
69,558
+6,622
| +11% | +$61.3K | 0.01% | 1464 |
|
|
2022
Q3 | $649K | Buy |
62,936
+4,655
| +8% | +$48K | 0.01% | 1132 |
|
|
2022
Q2 | $583K | Buy |
58,281
+4,628
| +9% | +$46.3K | 0.01% | 1171 |
|
|
2022
Q1 | $660K | Buy |
53,653
+21,785
| +68% | +$268K | 0.01% | 1127 |
|
|
2021
Q4 | $553K | Buy |
31,868
+794
| +3% | +$13.8K | 0.01% | 1221 |
|
|
2021
Q3 | $558K | Buy |
+31,074
| New | +$558K | 0.01% | 1151 |
|